UBS O'Connor’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-67,631
| Closed | -$41.4K | – | 315 |
|
|
2025
Q1 | $41.4K | Sell |
67,631
-241,127
| -78% | -$148K | ﹤0.01% | 238 |
|
|
2024
Q4 | $324K | Hold |
308,758
| – | – | 0.01% | 289 |
|
|
2024
Q3 | $605K | Buy |
308,758
+15,000
| +5% | +$29.4K | 0.02% | 324 |
|
|
2024
Q2 | $589K | Sell |
293,758
-2,917
| -1% | -$5.85K | 0.02% | 349 |
|
|
2024
Q1 | $409K | Hold |
296,675
| – | – | 0.01% | 341 |
|
|
2023
Q4 | $335K | Buy |
296,675
+975
| +0.3% | +$1.1K | 0.01% | 368 |
|
|
2023
Q3 | $447K | Buy |
295,700
+230,072
| +351% | +$347K | 0.01% | 394 |
|
|
2023
Q2 | $105K | Buy |
+65,628
| New | +$105K | ﹤0.01% | 461 |
|